The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7

Journal of Virology

Volumn 79, Issue 22, 2005, Pages 14309-14317

  Wise Draper, Trisha M ^a   Allen, Hillary V ^a   Thobe, Megan N ^a   Jones, Elizabeth E ^a   Habash, Kristen B ^a   Münger, Karl ^b   Wells, Susanne I ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Division of Hematology/Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; ONCOPROTEIN; ONCOPROTEIN DEK; PROTEIN E7; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIVISION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE E6; HUMAN PAPILLOMAVIRUS TYPE E7; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTO ONCOGENE; PROTO ONCOGENE DEK; SENESCENCE; UTERINE CERVIX CANCER; VIRUS INFECTION;

CELL AGING; CELL CYCLE; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; ONCOGENE PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; TUMOR VIRUS INFECTIONS;

ANIMALIA; CANCER VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 27644568474     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.22.14309-14317.2005     Document Type: Article

References (57)

1. Alexiadis, V., T. Waldmann, J. Andersen, M. Mann, R. Knippers, and C. Gruss. 2000. The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes Dev. 14:1308-1312.
2. Aravind, L., and E. V. Koonin. 2000. SAP-a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci. 25:112-114.
3. Arbeit, J. M., K. Munger, P. M. Howley, and D. Hanahan. 1994. Progressive squamous epithelial neoplasia in K14-HPV16 transgenic mice. J. Virol. 68: 4358-4368.
4. Campillos, M., M. A. Garcia, F. Valdivieso, and J. Vazquez. 2003. Transcriptional activation by AP-2α is modulated by the oncogene DEK. Nucleic Acids Res. 31:1571-1575.
5. Campisi, J. 2000. Cancer aging and cellular senescence. In Vivo 14:183-188.
6. 5a. Dannenberg, J.-H., A. van Rossum, L. Schuijff, and H. te Riele. 2000. Ablation of the retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 14:3051-3064.
7. Demeret, C., C. Desaintes, M. Yaniv, and F. Thierry. 1997. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71:9343-9349.
8. Desaintes, C., C. Demeret, S. Goyat, M. Yaniv, and F. Thierry. 1997. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16:504-514.
9. Desaintes, C., S. Goyat, S. Garbay, M. Yaniv, and F. Thierry. 1999. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene 18:4538-4545.
10. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, M. Peacocke, and J. Campisi. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
11. Dong, X., M. A. Michelis, J. Wang, R. Bose, T. DeLange, and W. H. Reeves. 1998. Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis. Arthritis Rheum. 41:1505-1510.
12. Dong, X., J. Wang, F. N. Kabir, M. Shaw, A. M. Reed, L. Stein, L. E. Andrade, V. F. Trevisani, M. L. Miller, T. Fujii, M. Akizuki, L. M. Pachman, M. Satoh, and W. H. Reeves. 2000. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum. 43:85-93.
13. Durst, M., A. Kleinheinz, M. Hotz, and L. Gissmann. 1985. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J. Gen. Virol. 66:1515-1522.
14. Ferenczy, A., and E. Franco. 2002. Persistent human papillomavirus infection and cervical neoplasia. Lancet iii:11-16.
15. Francis, D. A., S. I. Schmid, and P. M. Howley. 2000. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J. Virol. 74:2679-2686.
16. Fu, G. K., G. Grosveld, and D. M. Markovitz. 1997. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. Proc. Natl. Acad. Sci. USA 94:1811-1815.
17. Goodwin, E. C., and D. DiMaio. 2001. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres. Cell Growth Differ. 12:525-534.
18. Goodwin, E. C., and D. DiMaio. 2000. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. USA 97: 12513-12518.
19. Goodwin, E. C., E. Yang, C.-J. Lee, H.-W. Lee, D. DiMaio, and E.-S. Hwang. 2000. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97:10978-10983.
20. Grottke, C., K. Mantwill, M. Dietel, D. Schadendorf, and H. Lage. 2000. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int. J. Cancer 88: 535-546.
21. Hall, A. H., and K. A. Alexander. 2003. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J. Virol. 77:6066-6069.
22. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910.
23. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
24. Hollenbach, A. D., C. J. McPherson, E. J. Mientjes, R. Iyengar, and G. Grosveld. 2002. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J. Cell Sci. 115:3319-3330.
25. Howley, P. M., and D. R. Lowy. 2001. Papillomavirinae: the viruses and their replication, p. 2197-2229. In P. M. Howley and D. M. Knipe (ed.), Fields virology, 3rd ed., vol. 2. Lippincott Williams and Wilkins, Philadelphia, Pa.
26. Kang, H. T., C. J. Lee, E. J. Seo, Y. J. Bahn, H. J. Kim, and E. S. Hwang. 2004. Transition to an irreversible state of senescence in HeLa cells arrested by repression of HPV E6 and E7 genes. Mech. Ageing Dev. 125:31-40.
27. Kappes, F., K. Burger, M. Baack, F. O. Fackelmayer, and C. Gruss. 2001. Subcellular localization of the human proto-oncogene protein DEK. J. Biol. Chem. 276:26317-26323.
28. Kappes, F., C. Damoc, R. Knippers, M. Przybylski, L. A. Pinna, and C. Gruss. 2004. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK. Mol. Cell. Biol. 24:6011-6020.
29. Kappes, F., I. Scholten, N. Richter, C. Gruss, and T. Waldmann. 2004. Functional domains of the ubiquitous chromatin protein DEK. Mol. Cell. Biol. 24:6000-6010.
30. Kiyono, T., S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84-88.
31. Kondoh, N., T. Wakatsuki, A. Ryo, A. Hada, T. Aihara, S. Horiuchi, N. Goseki, O. Matsubara, K. Takenaka, M. Shichita, K. Tanaka, M. Shuda, and M. Yamamoto. 1999. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res. 59:4990-4996.
32. Krithivas, A., M. Fujimuro, M. Weidner, D. B. Young, and S. D. Hayward. 2002. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76: 11596-11604.
33. Kroes, R. A., A. Jastrow, M. G. McLone, H. Yamamoto, P. Colley, D. S. Kersey, V. W. Yong, E. Mkrdichian, L. Cerullo, J. Leestma, and J. R. Moskal. 2000. The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett. 156:191-198.
34. Larramendy, M. L., T. Niini, E. Elonen, B. Nagy, J. Ollila, M. Vihinen, and S. Knuutila. 2002. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis. Haematologica 87:569-577.
35. Lee, C. J., E. J. Suh, H. T. Kang, J. S. Im, U. S. J., J. S. Park, and E. S. Hwang. 2002. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA. Exp. Cell. Res. 277:173-182.
36. Li, F., G. Ambrosini, E. Y. Chu, J. Plescia, S. Tognin, P. C. Marchisio, and D. C. Altieri. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584.
37. Lloyd, A. C. 2002. Limits to lifespan. Nat. Cell Biol. 4:E25-E27.
38. McGarvey, T., E. Rosonina, S. McCracken, Q. Li, R. Arnaout, E. Mientjes, J. A. Nickerson, D. Awrey, J. Greenblatt, G. Grosveld, and B. J. Blencowe. 2000. The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. J. Cell Biol. 150: 309-320.
39. McMurray, H. R., and D. J. McCance. 2004. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7. J. Virol. 78:5698-5706.
40. Münger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
41. Pecoraro, G., D. Morgan, and V. Defendi. 1989. Differential effects of human papillomavirus type 6, 16 and 18 DNAs on immortalization and transformation of human cervical epithelial cells. Proc. Natl. Acad. Sci. USA 86: 563-567.
42. 105 promoters. J. Virol. 64:2849-2859.
43. Schwarz, E., U. K. Freese, L. Gissman, W. Mayer, B. Roggenbuck, A. Stremlan, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
44. Sierakowska, H., K. R. Williams, I. S. Szer, and W. Szer. 1993. The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis. Clin. Exp. Immunol. 94:435-439.
45. Sitwala, K. V., K. Adams, and D. M. Markovitz. 2002. YY1 and NF-Y binding sites regulate the transcriptional activity of the DEK and DEK-CAN promoter. Oncogene 21:8862-8870.
46. Sitwala, K. V., N. Mor-Vaknin, and D. M. Markovitz. 2003. Minireview: DEK and gene regulation, oncogenesis and AIDS. Anticancer Res. 23: 2155-2158.
47. Tan, S.-H., B. Gloss, and H.-U. Bernard. 1992. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res. 20:251-256.
48. 105 promoter. New Biol. 3:90-100.
49. von Lindern, M., M. Fornerod, N. Soekarman, S. van Baal, M. Jaegle, A. Hagemeijer, D. Bootsma, and G. Grosveld. 1992. Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. Baillieres Clin. Haematol. 5:857-879.
50. Waldmann, T., M. Baack, N. Richter, and C. Gruss. 2003. Structure-specific binding of the proto-oncogene protein DEK to DNA. Nucleic Acids Res. 31:7003-7010.
51. Waldmann, T., C. Eckerich, M. Baack, and C. Gruss. 2002. The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils. J. Biol. Chem. 277:24988-24994.
52. Waldmann, T., I. Scholten, F. Kappes, H. G. Hu, and R. Knippers. 2004. The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin. Gene 343:1-9.
53. Wehster, K., J. Parish, M. Pandya, P. L. Stern, A. R. Clarke, and K. Gaston. 2000. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J. Biol. Chem. 275:87-94.
54. Wells, S. I., B. J. Aronow, T. M. Wise, S. S. Williams, J. A. Couget, and P. M. Howley. 2003. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc. Natl. Acad. Sci. USA 100:7093-7098.
55. CIP-dependent pathways. EMBO J. 19:5762-5771.
56. Wichmann, I., N. Respaldiza, J. R. Garcia-Lozano, M. Montes, J. Sanchez-Roman, and A. Nunez-Roldan. 2000. Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 119:530-532.
57. Woodworth, C. D., J. Doninger, and J. A. DiPaolo. 1989. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J. Virol. 63:159-164.